Lazard Gains Market Share and 4 Stock Analyses to Track

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

LRR Energy LP (NYSE:LRE): Oppenheimer sees LRR Energy LP’s valuation as inviting ahead of expected acquisitions and balance sheet strengthening efforts. Shares are Outperform rated with a $24 price target.

Medicis Pharmaceutical Corp. (NYSE:MRX): Morgan Stanley said that the complaint filed by Q-Med should not stop Medicis Pharmaceutical Corp.  from closing the deal.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Lazard Ltd. (NYSE:LAZ): Argus believes that Lazard Ltd. has continued to gain M&A market share and they think that  company can meet their margin targets. The firm reiterates a Buy rating on their stock.

MAP Pharmaceuticals, Inc. (NASDAQ:MAPP): Cancaccord defended MAP Pharmaceuticals, Inc.’s shares.

J. C. Penney Company, Inc. (NYSE:JCP): Macquarie defended J.C. Penney Company, Inc.’s shares.

Don’t Miss: Keystone XL Pipeline Back in Focus as Obama Heads Into Second Term.

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business